Cited by 516Chronic Obstructive Pulmonary Disease (COPD) ResearchMedication Adherence and ComplianceInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Adherence to inhaled therapy, mortality and hospital admission in COPD

Open access

Vestbo, J, Anderson, J A, Calverley, P M A, Celli, B, Ferguson, G T, Jenkins, C, Knobil, K, Willits, L R, Yates, J C, Jones, P W·2009·Thorax

DOI 10.1136/thx.2009.113662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. METHODS: Data on drug adherence from a randomised double-blind trial comparing inhaled salmeterol 50 microg + fluticasone propionate 500 microg twice daily with placebo and each drug individually in 6112 patients with moderate to severe COPD over 3 years in the TORCH study were used. All-cause mortality and exacerbations leading to hospital admission were primary and secondary end points. The study of adherence was not specified a priori as an ancillary study. RESULTS: Of the 4880 patients (79.8%) with good adherence defined as >80% use of study medication, 11.3% died compared with 26.4% of the 1232 patients (20.2%) with poor adherence. The annual rates of hospital admission for exacerbations were 0.15 and 0.27, respectively. The association between adherence and mortality remained unchanged and statistically significant after adjusting for other factors related to prognosis (hazard ratio 0.40 (95% CI 0.35 to 0.46), p<0.001). The association was even stronger when analysing on-treatment deaths only. Similarly, the association between adherence and hospital admission remained unchanged and significant in a multivariate analysis (rate ratio 0.58 (95% CI 0.44 to 0.73, p<0.001). The association between increased adherence and improved mortality and reduction in hospital admission was independent of study treatment. The effect of treatment was more pronounced in patients with good adherence than in those with poor adherence. CONCLUSION: Adherence to inhaled medication is significantly associated with reduced risk of death and admission to hospital due to exacerbations in COPD. Further research is needed to understand these strong associations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/thx.2009.113662

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citation
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citation
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citation
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Rodríguez, R. (2007) · Cited by 1,412
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 3×
“treatment with a drug with positive effects to that in patients receiving placebo.(1) Most of the studies”
BackgroundMethodResultInfluential
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease A Disease-Specific Self-management Intervention
Bourbeau, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.585 · Cited by 933
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 616
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615

Show all 32 references

Sorted by citations

Chronic obstructive pulmonary disease
Barnes, P. J., Burney, P., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. �. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 761
Self-citation
Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD
Mäkelä, M. J., Backer, V., Hedegaard, M. S., & Larsson, K. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.04.005 · Cited by 485
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
Dransfield, M. T., Bourbeau, J., Jones, P., Hanania, N. A., Mahler, D. A., Vestbo, J., Wachtel, A., Martínez, F. J., Barnhart, F., Sanford, L., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70040-7 · Cited by 343
Self-citation
Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
Plaza, V., Fernández, C., Moreno, C. M., Cosío, B. G., Costa, L. M. E., de Llano, L. A. P., Pereyra, F. G., Tarragona, E., Palomino, R., López-Viña, A., et al. (2015) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1212 · Cited by 284
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Nannini, L. J., Poole, P., Milan, S. J., Holmes, R. S., & Normansell, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub4 · Cited by 276
The association between medication non‐adherence and adverse health outcomes in ageing populations: A systematic review and meta‐analysis
Walsh, C. A., Cahir, C., Tecklenborg, S., Byrne, C. J., Culbertson, M. A., & Bennett, K. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14075 · Cited by 294
Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease
Riley, C. M., & Sciurba, F. C. (2019) · JAMA · doi:10.1001/jama.2019.0131 · Cited by 267
Clinical and economic impact of non-adherence in COPD: A systematic review
van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Mölken, M. R., Postma, M. J., & Vegter, S. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.08.044 · Cited by 225
Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease
Sulaiman, I., Cushen, B., Greene, G., Seheult, J. N., Seow, D., Rawat, F., MacHale, E., Mokoka, M., Moran, C. N., Sartini-Bhreathnach, A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0733oc · Cited by 224
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A. G. N., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0044st · Cited by 230
Self-citation
Defining and targeting health disparities in chronic obstructive pulmonary disease
Pleasants, R. A., Riley, I. L., & Mannino, D. M. (2016) · International Journal of COPD · doi:10.2147/copd.s79077 · Cited by 219
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A. G. N., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00009015 · Cited by 205
Self-citation
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
Albert, P., Agustí, A. G. N., Edwards, L. D., Tal‐Singer, R., Yates, J., Bakke, P. S., Celli, B. R., Coxson, H. O., Crim, C. C., Lomas, D. A., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201458 · Cited by 187
Self-citation
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis
Kew, K. M., Dias, S., & Cates, C. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010844.pub2 · Cited by 179
Choosing the right inhaler for your asthma or COPD patient
Usmani, O. S. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s160365 · Cited by 161
Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease ( PHARMACOP ): a randomized controlled trial
Tommelein, E., Mehuys, E., Hees, T. J. V., Adriaens, E., Bortel, L. M. V., Christiaens, T. C., Tongelen, I. V., Remon, J., Boussery, K., & Brusselle, G. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12242 · Cited by 167
Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers
Yu, A. P., Guérin, A., de Leon, D. P., Ramakrishnan, K., Wu, E. Q., Mocarski, M., Blum, S., & Setyawan, J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.594123 · Cited by 155
Improving medication adherence in chronic obstructive pulmonary disease: a systematic review
Bryant, J., McDonald, V. M., Boyes, A., Sanson‐Fisher, R., Paul, C. L., & Melville, J. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-109 · Cited by 156
Using Robots at Home to Support Patients With Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial
Broadbent, E., Garrett, J., Jepsen, N., Li Ogilvie, V., Ahn, H. S., Robinson, H., Peri, K., Kerse, N., Rouse, P., Pillai, A., et al. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8640 · Cited by 119
“There are several risk factors for COPD-related hospital admissions, including nonadherence to medication [5].”
Background
Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population
Simoni, J. M., Wei, Y. J., Qian, J., Zuckerman, I. H., Stuart, B., Shaffer, T., Dalal, A. A., & Bryant‐Comstock, L. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.002 · Cited by 131
Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
Bollmeier, S. G., & Hartmann, A. P. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz306 · Cited by 131
New insights to improve treatment adherence in asthma and COPD
George, M., & Bender, B. G. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s209532 · Cited by 128
Effect of pharmacist‐led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta‐analysis
Jia, X., Zhou, S., Luo, D., Zhao, X., Zhou, Y. F., & Cui, Y. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13126 · Cited by 126
Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers
Jansen, E. M., van de Hei, S. J., Dierick, B. J. H., Kerstjens, H. A. M., Kocks, J. W. H., & van Boven, J. F. M. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-2360 · Cited by 126
Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service
Elliott, R. A., Boyd, M., Salema, N.-E., Davies, J. E., Barber, N., Mehta, R. L., Tanajewski, Ł., Waring, J. J., Latif, A., Gkountouras, G., et al. (2015) · BMJ Quality & Safety · doi:10.1136/bmjqs-2015-004400 · Cited by 113
Status of and strategies for improving adherence to COPD treatment
López-Campos, J. L., Quintana‐Gallego, E., & Hernández, L. C. (2019) · International Journal of COPD · doi:10.2147/copd.s170848 · Cited by 111
Adherence in Asthma and COPD: New Strategies for an Old Problem
George, M. (2018) · Respiratory Care · doi:10.4187/respcare.05905 · Cited by 113
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting
Yawn, B. P., & Colice, G. (2012) · International Journal of COPD · doi:10.2147/copd.s32674 · Cited by 105
Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
Nannini, L. J., Poole, P., Milan, S. J., & Kesterton, A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006826.pub2 · Cited by 103
A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD
Kerwin, E., Scott-Wilson, C. A., Sanford, L., Rennard, S. I., Agustí, A. G. N., Barnes, N. C., & Crim, C. C. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.014 · Cited by 101
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Humenberger, M., Horner, A., Labek, A., Kaiser, B., Frechinger, R., Brock, C., Lichtenberger, P., & Lamprecht, B. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0724-3 · Cited by 101
Adherence to COPD treatment: myth and reality
Rogliani, P., Ora, J., Puxeddu, E., Matera, M. G., & Cazzola, M. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.06.007 · Cited by 102
Beclomethasone/formoterol in the management of COPD: A randomised controlled trial
Calverley, P. M. A., Kuna, P., Monsó, E., Costantini, M., Petruzzelli, S., Sergio, F., Varoli, G., Papi, A. A., & Brusasco, V. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.008 · Cited by 101
Self-citation
Accuracy of the Medication Adherence Report Scale (MARS-5) as a Quantitative Measure of Adherence to Inhalation Medication in Patients With COPD
Tommelein, E., Mehuys, E., Tongelen, I. V., Brusselle, G., & Boussery, K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014522982 · Cited by 96
The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease
Beeh, K. M., & Beier, J. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0017-6 · Cited by 92
Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease
Takemura, Mitsui, Itotani, Ishitoko, Сузуки, Matsumoto, M., Aihara, Oguma, Ueda, T., Kagioka, et al. (2011) · International Journal of COPD · doi:10.2147/copd.s16173 · Cited by 94
Predicting and preventing hospital readmission for exacerbations of COPD
Kong, C. W., & Wilkinson, T. M. A. (2020) · ERJ Open Research · doi:10.1183/23120541.00325-2019 · Cited by 98
Treatment adherence and health outcomes in patients with bronchiectasis
McCullough, A. R., Tunney, M. M., Quittner, A. L., Elborn, J. S., Bradley, J. M., & Hughes, C. M. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-107 · Cited by 87
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study
Chapman, K. R., Beeh, K. M., Beier, J., Bateman, E. D., D’Urzo, A. D., Nutbrown, R., Henley, M., Chen, H., Overend, T., & D’Andrea, P. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-4 · Cited by 86
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)
Levy, M. L., Dekhuijzen, P. N. R., Barnes, P. J., Broeders, M. E. A. C., Corrigan, C. J., Chawes, B., Corbetta, L., Dubus, J. ‐., Hausen, T., Lavorini, F., et al. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2016.17 · Cited by 86
Adherence to Long-Acting Inhaled Therapies among Patients with Chronic Obstructive Pulmonary Disease (COPD)
Cecere, L. M., Slatore, C. G., Uman, J. E., Evans, L., Udris, E. M., Bryson, C. L., & Au, D. H. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.650241 · Cited by 92
Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective
Chan, A. H. Y., Pleasants, R. A., Dhand, R., Tilley, S. L., Schworer, S. A., Costello, R. W., & Merchant, R. K. (2021) · Pulmonary Therapy · doi:10.1007/s41030-021-00167-4 · Cited by 84
Why Don’t Our Patients with Chronic Obstructive Pulmonary Disease Listen to Us? The Enigma of Nonadherence
Blackstock, F. C., ZuWallack, R., Nici, L. L., & Lareau, S. C. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201509-600ps · Cited by 85
Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for OSA
Justeau, G., Gervès‐Pinquié, C., Vaillant, M. L., Trzépizur, W., Meslier, N., Goupil, F., Pigeanne, T., Launois, S. H., Leclair‐Visonneau, L., Masson, P., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.055 · Cited by 89
Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD
Tøttenborg, S. S., Lange, P., Johnsen, S. P., Nielsen, H., Ingebrigtsen, T. S., & Thomsen, R. W. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.09.007 · Cited by 83
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?
Dekhuijzen, R. P. N., Lavorini, F., Usmani, O. S., & van Boven, J. F. M. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.11.027 · Cited by 84
COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation
Pierobon, A., Bottelli, E. S., Ranzini, L., Bruschi, C., Maestri, R., Bertolotti, G., Sommaruga, M., Torlaschi, V., Callegari, S., & Giardini, A. (2017) · International Journal of COPD · doi:10.2147/copd.s133586 · Cited by 82
COPD care delivery pathways in five European Union countries: mapping and health care professionals’ perceptions
Kayyali, R., Odeh, B., Frerichs, I., Davies, N., Perantoni, E., D’Arcy, S., Vaes, A. W., Chang, J. K., Spruit, M. A., Deering, B. M., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s104136 · Cited by 82
The importance of components of pulmonary rehabilitation, other than exercise training, in COPD
Hill, K., Vogiatzis, I., & Burtin, C. (2013) · European Respiratory Review · doi:10.1183/09059180.00002913 · Cited by 81
Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations
van Boven, J. F. M., Ryan, D. P., Eakin, M. N., Canonica, G. W., Barot, A., & Foster, J. M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.03.007 · Cited by 81
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
Svedsäter, H., Dale, P., Garrill, K., Walker, R. W., & Woepse, M. W. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-72 · Cited by 77
Older patient, physician and pharmacist perspectives about community pharmacists' roles
Tarn, D. M., Paterniti, D. A., Wenger, N. S., Williams, B. R., & Chewning, B. A. (2012) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2012.00202.x · Cited by 81
Controversies in treatment of chronic obstructive pulmonary disease
Rabe, K. F., & Wedzicha, J. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61295-6 · Cited by 75
Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: A Systematic Review
Bhattarai, B., Walpola, R. L., Mey, A., Anoopkumar‐Dukie, S., & Khan, S. A. (2020) · Respiratory Care · doi:10.4187/respcare.07355 · Cited by 79
Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
van Boven, J. F. M., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G., Mölken, M. R., & Postma, M. J. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-66 · Cited by 77
Chronic obstructive pulmonary disease ( COPD ) mortality trends worldwide: An update to 2019
Mei, F., Dalmartello, M., Bonifazi, M., Bertuccio, P., Levi, F., Boffetta, P., Negri, E., Vecchia, C. L., & Malvezzi, M. (2022) · Respirology · doi:10.1111/resp.14328 · Cited by 75
Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices
Lavorini, F., Mannini, C., Chellini, E., & Fontana, G. A. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0377-y · Cited by 72
Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset
Mueller, S., Wilke, T., Bechtel, B., Punekar, Y. S., Mitzner, K., & Virchow, J. C., Jr. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.008 · Cited by 71
Guideline adherence in management of stable chronic obstructive pulmonary disease
Sharif, R., Cuevas, C., Wang, Y., Arora, M., & Sharma, G. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.04.001 · Cited by 72
Effect of pharmaceutical care on medication adherence and hospital admission in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled study.
Li, W., Yang, X., Li, J., Liu, L., Luo, H., Zheng, Z., & Wei, Y. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.06.20 · Cited by 67
Inhaler Technique Education and Exacerbation Risk in Older Adults with Asthma or Chronic Obstructive Pulmonary Disease: A Meta‐Analysis
Maricoto, T., Monteiro, L., Gama, J. M. R., Correia‐de‐Sousa, J., & Taborda‐Barata, L. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15602 · Cited by 69
Irregular and Ineffective: A Quantitative Observational Study of the Time and Technique of Inhaler Use
Sulaiman, I., Seheult, J. N., MacHale, E., D’Arcy, S., Boland, F., McCrory, K., Casey, J., Bury, G., Al‐Alawi, M., O'Dwyer, S., et al. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.07.009 · Cited by 69
Low Use and Adherence to Maintenance Medication in Chronic Obstructive Pulmonary Disease in the General Population
Ingebrigtsen, T. S., Marott, J. L., Nordestgaard, B. G., Lange, P., Hallas, J., Dahl, M., & Vestbo, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3029-0 · Cited by 68
Self-citation
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice
Elliott, R. A., Tanajewski, Ł., Gkountouras, G., Avery, A. J., Barber, N., Mehta, R. L., Boyd, M., Latif, A., Chuter, A., & Waring, J. J. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0554-9 · Cited by 66
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study
de, M. M., Menezes, A. M. B., Wehrmeister, F. C., Varela, M. V. L., Casas, A., Ugalde, L., Ramírez‐Venegas, A., I, L. M., López, A. M., Surmont, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186777 · Cited by 68
Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients
Plaza, V., López-Viña, A., Costa, L. M. E., Fernández, C., Moreno, C. M., Pérez-Llano, L., Pereyra, F. G., Tarragona, E., Palomino, R., & Cosío, B. G. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1118449 · Cited by 64
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study
Mannino, D. M., Bogart, M., Wu, B., Germain, G., Laliberté, F., MacKnight, S. D., Jung, Y. Y., Stiegler, M. P., & Duh, M. S. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106807 · Cited by 62
Helping COPD patients change health behavior in order to improve their quality of life
Almagro, P., & Castro (2013) · International Journal of COPD · doi:10.2147/copd.s34211 · Cited by 60
Efficacy and Safety of a Fixed-Dose Combination of Indacaterol and Glycopyrronium for the Treatment of COPD
Rodrigo, G. J., & Plaza, V. (2014) · CHEST Journal · doi:10.1378/chest.13-2807 · Cited by 56
The Clinical Impact of Different Adherence Behaviors in Patients with Severe Chronic Obstructive Pulmonary Disease
Cushen, B., Sulaiman, I., Greene, G., MacHale, E., Mokoka, M., Reilly, R. B., Bennett, K., Doyle, F., van Boven, J. F. M., & Costello, R. W. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2469le · Cited by 56
Self-management behaviour and support among primary care COPD patients: cross-sectional analysis of data from the Birmingham Chronic Obstructive Pulmonary Disease Cohort
Khan, A., Dickens, A., Adab, P., & Jordan, R. (2017) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-017-0046-6 · Cited by 55
How to Choose the Right Inhaler Using a Patient-Centric Approach?
Cataldo, D. D., Hanon, S., Peché, R., Schuermans, D., Degryse, J., Wulf, I. A. D., Elinck, K., Leys, M. H., Rummens, P., & Derom, E. (2022) · Advances in Therapy · doi:10.1007/s12325-021-02034-9 · Cited by 55
A comprehensive hospital-based intervention to reduce readmissions for chronically ill patients: a randomized controlled trial.
Linden, A., & Butterworth, S. W. (2014) · PubMed · Cited by 55
Predictors of Adherence to Inhaled Medications Among Veterans with COPD
Huetsch, J., Uman, J. E., Udris, E. M., & Au, D. H. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2130-5 · Cited by 55
Nonadherence in chronic obstructive pulmonary disease patients
Bender, B. G. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000027 · Cited by 55
Adherence to COPD treatment in Turkey and Saudi Arabia: Results of the ADCARE study
Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s150411 · Cited by 53
“Data from the TORCH study reports no association between adherence to treatment and symptom severity as defined by Global Initiative for Obstructive Lung Disease (GOLD) stage, although patients with poor adherence did have lower baseline FEV 1 and increased dyspnea.(42) Similar findings were reported by another study…”
Result
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
Janjua, S., Pike, K. C., Carr, R., Coles, A., Normansell, R., & Batavia, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013381.pub2 · Cited by 52
Real-life inhaler adherence and technique: Time to get smarter!
Chrystyn, H., Audibert, R., Keller, M., Quaglia, B., Vecellio, L., & Roche, N. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.09.008 · Cited by 56
Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease
von Leupoldt, A., Fritzsche, A., Trueba, A. F., Meuret, A. E., & Ritz, T. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9348-7 · Cited by 53
A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
Agustí, A. G. N., de Teresa, L., Backer, W. D., Zvarich, M. T., Locantore, N., Barnes, N. C., Bourbeau, J., & Crim, C. C. (2013) · European Respiratory Journal · doi:10.1183/09031936.00054213 · Cited by 52
Chronic obstructive pulmonary disease (COPD) and old age?
Jarad, N. A. (2011) · Chronic Respiratory Disease · doi:10.1177/1479972311407218 · Cited by 52
Test of Adherence to Inhalers
Plaza, V., López-Viña, A., & Cosío, B. G. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2017.03.005 · Cited by 52
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
Halpin, D. M. G., Rothnie, K., Banks, V., Czira, A., Compton, C. H., Wood, R. P., Tritton, T., Massey, O., Wild, R., Snowise, N. G., et al. (2022) · International Journal of COPD · doi:10.2147/copd.s370540 · Cited by 51
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD
Yu, A. P., Guérin, A., de Leon, D. P., Ramakrishnan, K., Wu, E. Q., Mocarski, M., Blum, S. I., & Setyawan, J. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.001 · Cited by 51
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease
Qian, J., Simoni‐Wastila, L., Rattinger, G. B., Zuckerman, I. H., Lehmann, S. W., Wei, Y. J., & Stuart, B. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3968 · Cited by 50
Inhaler Adherence in COPD: A Crucial Step Towards the Correct
Turégano-Yedro, M., Trillo‐Calvo, E., Ros, F. M. N., Viejo, J. D. M., Villaescusa, C. G., Sustaeta, J. M. E., Doña, E., & Navarrete, B. A. (2023) · International Journal of COPD · doi:10.2147/copd.s431829 · Cited by 50
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates
Alshabanat, A., Otterstatter, M. C., Sin, D. D., Road, J., Rempel, C., Burns, J., van Eeden, S. V., & Fitzgerald, J. (2017) · International Journal of COPD · doi:10.2147/copd.s124385 · Cited by 49
Inhaler Training Delivered by Internet-Based Home Videoconferencing Improves Technique and Quality of Life
Thomas, R. M., Locke, E. R., Woo, D. M., Nguyen, E. H. K., Press, V. G., Layouni, T. A., Trittschuh, E. H., Reiber, G. E., & Fan, V. S. (2017) · Respiratory Care · doi:10.4187/respcare.05445 · Cited by 51
Building toolkits for COPD exacerbations: lessons from the past and present
Sapey, E., Bafadhel, M., Bolton, C. E., Wilkinson, T. M. A., Hurst, J. R., & Quint, J. K. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-213035 · Cited by 50
The Effect Of Veterans Health Administration Coverage On Cost-Related Medication Nonadherence
Gaffney, A. W., Bor, D. H., Himmelstein, D. U., Woolhandler, S. J., & McCormick, D. (2020) · Health Affairs · doi:10.1377/hlthaff.2019.00481 · Cited by 50
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
Singh, D., Emirova, A., Francisco, C., Santoro, D., Govoni, M., & Nandeuil, M. A. (2020) · Respiratory Research · doi:10.1186/s12931-020-01512-y · Cited by 48
Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease
Özyılmaz, E., Köktürk, N., Teksut, G., & Tatlicioğlu, T. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12150 · Cited by 48
Changes in Mortality Among US Adults With COPD in Two National Cohorts Recruited From 1971-1975 and 1988-1994
Ford, E. S., Mannino, D. M., Zhao, G., Li, C., & Croft, J. B. (2011) · CHEST Journal · doi:10.1378/chest.11-0472 · Cited by 47
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature
Monteiro, C., Maricoto, T., Prazeres, F., Simões, P. A., & Simões, J. A. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106724 · Cited by 53
Nurses’ Knowledge of Inhaler Technique in the Inpatient Hospital Setting
Tratto, K. D., Gomez, C., Ryan, C. J., Bracken, N. E., Steffen, A. D., & Corbridge, S. (2014) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000047 · Cited by 46
Adherence to controller therapy for chronic obstructive pulmonary disease: a review
Charles, M. S., Blanchette, C. M., Silver, H., Lavallee, D. C., Dalal, A. A., & Mapel, D. W. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.516284 · Cited by 46
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
Hsieh, M., Huang, S., Yang, T., Tao, C., Cheng, S.-L., Lee, C.-H., Kuo, P., Wu, Y., Chen, N., Hsu, W., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s176065 · Cited by 45
Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients
Ismaila, A., Corriveau, D., Vaillancourt, J., Parsons, D., Dalal, A., Su, Z. Z., & Sampalis, J. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.908828 · Cited by 45
The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study
Xin, C., Xia, Z., Jiang, C. S., Lin, M., & Li, G. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s110167 · Cited by 45
Advances in Audio-Based Systems to Monitor Patient Adherence and Inhaler Drug Delivery
Taylor, T. E., Zigel, Y., Looze, C. D., Sulaiman, I., Costello, R. W., & Reilly, R. B. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.08.1162 · Cited by 46

Authors: Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W.
Affiliations: University of Manchester (GB)
GlaxoSmithKline (United Kingdom) (GB)
Aintree University Hospital (GB)
Tufts University (US)
Woolcock Institute of Medical Research (AU)
GlaxoSmithKline (United States) (US)
St George's, University of London (GB)
Corresponding author: Vestbo, J
ORCID: Vestbo, J
Anderson, J A
Calverley, P M A
Celli, B
Ferguson, G T
Jenkins, C
Yates, J C
Jones, P W
Venue: Thorax
Publisher: BMJ
Published: 2009-08-23
Volume: 64
Issue: 11
Pages: 939-943
ISSN: 0040-6376 (ISSN-L)
DOI: 10.1136/thx.2009.113662
OpenAlex: W2095666112
Cited by: 516
References: 32
Citations by year: 2026: 17 · 2025: 22 · 2024: 36 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 45 · 2019: 36 · 2018: 33 · 2017: 32 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 31 · 2012: 17
FWCI: 15.15
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Thorax (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: chronic obstructive pulmonary disease, medication adherence, inhalation therapy, salmeterol, fluticasone propionate, all-cause mortality, hospitalization, COPD exacerbations, TORCH trial
MeSH terms: Fluticasone, Salmeterol Xinafoate, Administration, Inhalation, Adult, Aged, Aged, 80 and over, Albuterol, Androstadienes, Bronchodilator Agents, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Epidemiologic Methods, Female, Hospitalization, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adherence to inhaled therapy, mortality and hospital admission in COPD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks